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PROSTATE CANCER A SIGNIFICANT PROBLEM?
Frances Burge, Sadmeet Singh, Owen Cole. Nottingham University
Hospitals NHS Trust - City Campus
Introduction: LHRH agonist therapy is commonly employed in treating
advanced prostate cancer. LHRH agonist-induced hypogonadism causes
osteoporosis and is reported to signiﬁcantly increase the rate of osteopo-
rotic fractures in these patients. Measures to decrease fracture risk,
including bisphosphonate therapy, have been advocated. We sought to
evaluate the clinical burden of skeletal complications in men treated with
long-term LHRH agonists.
Patients and Methods: Patients commenced on indeﬁnite LHRH agonist
therapy at our unit between June 2004 and June 2005 were identiﬁed by
pharmacy records. Retrospective case note review established rates, cause
and time to fracture.
Results: 139 patients with a mean age of 76 were identiﬁed. By October
2009, 60% had died. 68% underwent bone scintigraphy, of these 59% were
positive. 9(6%) fractures were identiﬁed and osteoporosis was evident
amongst 6(4%). The median time to fracture was 39 months.
Discussion: Our Study Group had high risk, high grade disease and a high
mortality rate. They also had multiple risk factors for osteoporosis in
addition to LHRRH agonist therapy. In spite of this, the rate of osteoporotic
fracturewas low. Our ﬁndings challenge the view that men commenced on
long-term LHRH agonist therapy should, in general, be given prophylaxis
against osteoporosis.COST-EFFECTIVENESS OF BOTULINUM TYPE A TOXIN USE IN PRIMARY
AXILLARY HYPERHIDROSIS (AH)
Jakub Kaczynski, Louis Fligelstone. ABM University Health Board,
Morriston Hospital
Introduction: The commonest treatments for AH are intradermal injec-
tion of type A botulinum toxin(BTA) and iontophoresis, but there is lack of
consensus regarding the ideal ﬁrst line therapy. AIM Assessment of ﬁrst
line BTA therapy for AH. Patient satisfaction and cost effectiveness for BTA
versus iontophoresis was analysed.
Methods: All patients receiving BTA for AH at ABM University Health
Board between 2007-2009. Pre and post treatment Hyperhidrosis Disease
Severity(HDS) scores were recorded. The Finance Department provided
costing of staff, equipment and BTA.
Results: 39 patients , median patients age was 28 years(17-70), F:M ratio
3:1. Disease severity on HDS scale was scored by all patients as severe
hyperhidrosis. Each patient required median of 2(1-5) BTA sessions. The
median improvement was 3 points equivalent to¼ 80% reduction in sweat
production. Median therapeutic BTA effect lasted 150 days(60-360).
Satisfaction scores were in: 76% excellent, very good 21% and good 3%. Cost
for BTA treatment was £ 29.210,16 whilst iontophoresis cost for the same
group of patients would have been £ 10.943.4 producing a potential cost
saving of £ 18.266,76.
Conclusions: Iontophoresis should be reconsidered for ﬁrst line therapy
in selected patients based on cost-effectiveness analysis.IN HOSPITAL MORTALITY FOR OCTOGENARIANS WITH RUPTURED
ABDOMINAL AORTIC ANEURYSM
R.R. Makar, P. Wong, E.L. Wales, M.J. Clarke, M.G. Wyatt. Northern Vascular
Centre, Freeman Hospital, NewcastleIntroduction: The aim of this study was to determine in-patient mortality
in patients >80years, to determine whether our policy of operating on this
group can be justiﬁed. Method Peri-operative variables and operative
outcomes were prospectively recorded in consecutive patients undergoing
rAAA. Variables analysed included pre-existing co-morbidities, pre-oper-
ative minimum systolic blood pressure, maximum pulse rate, pre-opera-
tive haemoglobin and serum creatinine, duration of surgery. In-patient
mortality was compared between <80 years old patients (Group-I) and
patients >80 years old (Group-II).
Results: During 9 year period, 315 consecutive patients (M:F ¼ 263:52)
underwent repair of rAAA. Of these, 220 were in Group-I (median age 73y,
range 49-79) and 95 were in Group-II (median 83y, range 80-93). The
overall in-hospital mortality was 39% (31.4% for Group I and 56.8% for
Group-II, p<0.001). There were no statistically signiﬁcant differences
between the two groups in terms of co-morbidities or other peri-operative
variables, except a higher female:male ratio in Group-II.
Conclusion: This study conﬁrms that the in-hospital mortality for rAAA
elderly patients aged >80yrs is signiﬁcantly higher than for younger
patients. Nevertheless, over 40% of patients >80 years survived surgery
and were discharged from hospital alive. Longer term outcome analysis
would be required to justify this policy.A COMPARISON OF OUTCOMES FOR CONSULTANT VERSUS TRAINEE
PERFORMED STANDARDISED RADICAL OESOPHAGEAL RESECTION IN
A REGIONAL UNIT
G.W. Beattie, K. McManus, C. Austin, A. Graham, J.A. McGuigan. Royal
Victoria Hospital Belfast
Objective: To assess difference in duration of surgical procedure, length
of hospital stay, complications and in hospital mortality between
consultant and sub-consultant performed procedures with consultant
assistance.
Methods: We retrieved data on 453 consecutive oesophagectomies
from 1995-2008. To standardise comparisons we selected the radical
total thoracic oesophagectomy [TTO] with two ﬁeld lymph node
clearance.
Results: 322 patients underwent TTO, 162 were performed by sub-
consultants. Mean operative time for sub-consultants was 3hrs 54.5
minutes, as opposed to 3hrs 43minutes for consultants. Major complica-
tions included anastomotic leak, respiratory failure, chylothorax, hae-
morrhage and prolonged ICU stay. There were 24 for this category for
sub-consultants and 31 for consultants. Minor complications included
Atrial ﬁbrillation, sputum retention and atelectsis. There were 28 for sub-
consultants and 35 for consultants. In hospital mortality was reported on
the database as 3 for sub-consultants and 3 for consultants. Mean post-
operative stay was 14.9 days overall. Mean post-operative stay was 16.26
days for sub-consultants and 13.84 days for consultants.
Conclusions: No signiﬁcant differences were found in this series for
length of operation and measured clinical outcomes between cases per-
formed by sub-consultants and consultants. With appropriate consultant
assistance sub-consultants can provide excellent standards of care in
major oesophageal resections.AUDIT OF SURGICAL MANAGEMENT OF INTRADURAL SPINAL TUMOURS
AT SALFORD ROYAL HOSPITAL
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